Adalimumab therapy for childhood uveitis

Journal of Pediatrics

Volumn 149, Issue 4, 2006, Pages 572-575

  Vazquez Cobian, Liza B ^a   Flynn, Thomas ^a   Lehman, Thomas J A ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MALE; PAIN; PRIORITY JOURNAL; RANK SUM TEST; SIDE EFFECT; UVEITIS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 33749131976     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.04.058     Document Type: Article

References (22)

1. Dana M.R., Merayo-Lloves J., Schaumberg D.A., and Forster C.S. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 104 (1997) 236-244
2. Foster C.S. Diagnosis and treatment of juvenile idiopathic arthritis associated uveitis. Current Opin Ophthalmol 14 (2003) 395-398
3. BenEzra D., Cohen E., and Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol 89 (2005) 444-448
4. Cassidy J.T., Levinson J.E., Bass J.C., Baum J., Brewer Jr. E.J., Fink C.W., et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29 (1986) 274-281
5. Santos Lacomba M., Marcos Martin C., Gallardo Galera J.M., Gomez Vidal M.A., Collantes Estevez E., Ramirez Chamond R., et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 33 (2001) 251-255
6. Dick A.D., Duncan L., Hale G., Waldmann H., and Issacs J. Neutralizing TNF alpha activity modulates T cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmune 11 (1998) 255-264
7. Joseph A., Raj D., Dua H.S., Powell P.T., Lanyon P.C., and Powell R.J. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 110 (2003) 1449-1453
8. Reiff A., Takei S., Sadeghi S., Stout A., Shaham B., Bernstein B., et al. Etanercept therapy in children with treatment resistant uveitis. Arthritis Rheum 44 (2001) 1411-1415
9. Foster C.S., Tufail F., Waheed N.K., Chu D., Miserocchi E., Baltatzis S., et al. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmology 121 (2003) 437-440
10. Sfikakis P.P., Theodossiadis P.G., Katsiari C.G., Kaklamanis P., and Markomichelakis N.N. Effect of Infliximab on sight threatening panuveitis in Behcet's disease. Lancet 358 (2001) 295-296
11. Murphy C.C., Ayliffe W.H., Booth A., Makanjuola D., Andrews P.A., and Jayne D. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111 (2004) 352-356
12. Falappone P.C.F., Iannone F., Scioscia C., Grattagliano V., Covelli M., and Lapadula G. The treatment of recurrent uveitis with TNF alpha inhibitors. Rheumatismo 56 (2004) 185-189
13. El-Shabrawi Y., Mangge H., and Hermann J. Anti-tumor necrosis factor alpha treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment. Ann Rheum Dis 62 (2003) 1243-1244
14. Mangge H., Heinzl B., Grubbauer H.M., El-Shabrawi Y., and Schauenstein K. Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis. Rheumatol Int 23 (2003) 258-261
15. Smith J.R., Levinson R.D., Holland G.N., Jabs D.A., Robinson M.R., Whitcup S.M., et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 45 (2001) 252-257
16. Smith J.A., Thompson D.J., Whitcup S.M., Suhler E., Clarke G., Smith S., et al. A randomized, placebo controlled, double masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 53 (2005) 18-23
17. Nestorov I. Clinical pharmacokinetics of TNF antagonists: how do they differ?. Semin Arthritis Rheum 34 supp l1 (2005) 12-18
18. Foster C.S., and Vitale A.T. Diagnosis and Treatment of Uveitis (2002), Saunders, Philadelphia
19. Rosenberg K.D., Feuer W.J., and Davis J.L. Ocular complications of pediatric uveitis. Ophthalmology 111 (2004) 2299-2306
20. Jabs D.A., Rosenbaum J.T., Foster C.S., Holland G.N., Jaffe G.J., Louis J.S., et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130 (2000) 492-513
21. Hashkes P.J., and Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatology 21 (2003) 645-646
22. Tillakos A.N., and Tiliakos N.A. Ocular inflammatory disease in patients with rheumatoid arthritis taking etanercept; is discontinuation of etanercept necessary?. J Rheumatol 30 (2003) 2727